Especially relevant in light of their torcetrapib disaster. They’re working on an OTC and spray version of Viagra. That’s just what we need. (via PharmaGossip)
How Pfizer plans to increase revenue
More in Uncategorized
-
Most Popular
Past Week
-
Why feeling unlike yourself is a sign of physician emotional overload
Stephanie Wellington, MD | Physician -
The loss of community pharmacy expertise
Muhammad Abdullah Khan | Conditions -
Accountable care cooperatives: a community-owned health care fix
David K. Cundiff, MD | Policy -
Preventive health care architecture: a global lesson
Gerald Kuo | Conditions -
The emotional toll of trauma care
Veronica Bonales, MD | Physician -
Modern eugenics: the quiet return of a dangerous ideology
Arthur Lazarus, MD, MBA | Physician
-
Past 6 Months
-
Direct primary care in low-income markets
Dana Y. Lujan, MBA | Policy -
Patient modesty in health care matters
Misty Roberts | Conditions -
The U.S. gastroenterologist shortage explained
Brian Hudes, MD | Physician -
The Silicon Valley primary care doctor shortage
George F. Smith, MD | Physician -
California’s opioid policy hypocrisy
Kayvan Haddadan, MD | Conditions -
A lesson in empathy from a young patient
Dr. Arshad Ashraf | Physician
-
Recent Posts
-
The emotional toll of trauma care
Veronica Bonales, MD | Physician -
Preserving clinical judgment in the age of clinical AI tools
Gerald Kuo | Conditions -
What is a loving organization?
Apurv Gupta, MD, MPH & Kim Downey, PT & Michael Mantell, PhD | Conditions -
Why humanity in medicine requires peace with a spine
Kathleen Muldoon, PhD | Conditions -
The loss of community pharmacy expertise
Muhammad Abdullah Khan | Conditions -
How should kratom be regulated? [PODCAST]
The Podcast by KevinMD | Podcast
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.










![How should kratom be regulated? [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-2-190x100.jpg)